Mirexus Biotechnologies
Mirexus Biotechnologies is a privately-held biotech startup founded in 2008 that commercializes a "green" polysaccharide sub-micron particle platform for personal care, nutraceutical, biomedical, and specialty food applications, backed by approximately $15.8M in venture funding from Goddard Enterprises, GreenSky Ventures, and Asahi Kasei.
- Company typePrivate
- Founded2008
- HeadquartersShawnee On Delaware, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Mirexus Biotechnologies firmographics
Firmographics- Name
- Mirexus Biotechnologies
- Website
- https://mirexus.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Unknown
- Headcount range
- 11–50 employees
- Short description
- Mirexus Biotechnologies is a privately-held biotech startup founded in 2008 that commercializes a "green" polysaccharide sub-micron particle platform for personal care, nutraceutical, biomedical, and specialty food applications, backed by approximately $15.8M in venture funding from Goddard Enterprises, GreenSky Ventures, and Asahi Kasei.
- Ownership category
- akta.pro rank
Mirexus Biotechnologies industry classification
Industry- Product category
- Biopolymer Ingredients
- NAICS
- Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing (3252)
- SIC
- Miscellaneous Chemical Products (2890), Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) (2820)
- akta.pro primary industry
- Bio-based Materials & Fibers (e.g., cellulose derivatives, lignin-based materials, nanocellulose) (EUAAAIAD)
- akta.pro secondary industries
- Cellulose-Based Biodegradable Materials (cellulose films, fibers, derivatives) (IMAEAOAE), Compostable & Bio-Based Packaging (PLA/PHA, Starch Blends, Cellulose Films) (IMALAMAB), Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, PBAT) (IMANANAA)
Keywords
Where Mirexus Biotechnologies is headquartered
LocationHeadquarters
- HQ city
- Shawnee On Delaware
- HQ country
- United States
- HQ region
- North America
Markets served
Mirexus Biotechnologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales
Mirexus Biotechnologies product offering
Product offeringCore offering
Mirexus Inc. commercializes a novel "green" technology for producing polysaccharide sub-micron particles, which it sells as a biopolymer ingredient to industrial customers. The company's core output is the manufactured sub-micron particle itself, derived through an environmentally friendly process and intended for incorporation into downstream formulated products across relevant industries.
Differentiator
Problem solved
Functional benefit
Products and services
- Polysaccharide sub-micron particles Naturally derived polysaccharide-based sub-micron particles produced via the company's proprietary "green" technology, sold as a specialty biopolymer ingredient to industrial manufacturers and formulators.
Companies that use Mirexus Biotechnologies
Customer profileIdeal customer profiles1 record
Mirexus Biotechnologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Mirexus Biotechnologies competitors and assessment
Company assessmentDirect peers
- EcoSynthetix: Canadian bio-based specialty materials company producing sustainable polysaccharide-derived additives and binders. Direct peer to Mirexus given shared Canadian roots, sugar-based feedstock, and focus on commercializing green specialty ingredients for industrial and consumer applications.
- CelluForce: Canadian nanocrystalline cellulose (NCC) producer commercializing CelluForce NCC for industrial, personal care, and oil and gas uses. Closest direct comparable by technology type (bio-based sub-micron particles) and end-market overlap.
Emerging players
- Anomera: Canadian startup developing nanocellulose-based ingredients for cosmetics, personal care, and industrial markets. Emerging player with similar platform-technology approach and overlapping target customer base in personal care.
Broad incumbents
- Borregaard: Norwegian producer of lignin-based biopolymers and specialty ingredients for industrial and consumer applications. Broad incumbent operating at commercial scale in adjacent bio-based specialty materials.
- Sappi Biotech: Diversified pulp and paper group with a dedicated biotechnology arm commercializing nanocellulose and wood-based biopolymers. Broad incumbent with overlapping technology base and a more developed commercialization engine.
- Roquette: Global leader in plant-based ingredients (starches, polyols, biopolymers) serving food, nutrition, and industrial markets. Broad incumbent providing scale competition in bio-based specialty ingredients that could substitute or compete with Mirexus's polysaccharide nanoparticles.
- Ingredion: Major global ingredient supplier of plant-derived sweeteners, starches, and biomaterials for food, beverage, and personal care. Broad incumbent operating at scale across Mirexus's target end markets.
- CP Kelco: Global biopolymers producer using fermentation to manufacture specialty hydrocolloids (xanthan, gellan, carrageenan alternatives) for food, personal care, and industrial applications. Comparable in fermentation-derived polysaccharide ingredients and customer overlap.
- Tate & Lyle: Global ingredient company producing fermentation-derived specialty food and beverage ingredients. Broad incumbent with comparable feedstock-to-ingredient fermentation model and overlapping food and personal care customer base.
Others
- Asahi Kasei: Japanese diversified chemicals and materials conglomerate that is a strategic investor in Mirexus. Not a direct competitor but a strategic partner/investor whose portfolio includes specialty polymers, fibers, and biomedical materials relevant to Mirexus's downstream applications.
Market position
Customer concentration
Mirexus Biotechnologies social profiles
Digital presenceMirexus Biotechnologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mirexus Biotechnologies leadership team
Management profileNumber of profiles
Profiles3 records
Mirexus Biotechnologies funding detail
Funding detailFunding overview
Funding rounds3 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mirexus Biotechnologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mirexus Biotechnologies
What does Mirexus Biotechnologies do?
Mirexus Inc. commercializes a novel "green" technology for producing polysaccharide sub-micron particles, which it sells as a biopolymer ingredient to industrial customers. The company's core output is the manufactured sub-micron particle itself, derived through an environmentally friendly process and intended for incorporation into downstream formulated products across relevant industries.
When was Mirexus Biotechnologies founded?
Mirexus Biotechnologies was founded in 2008. It employs 11 to 50 people.
Where is Mirexus Biotechnologies based?
Mirexus Biotechnologies is headquartered in Shawnee On Delaware, United States, in the North America region.
Who are Mirexus Biotechnologies's main competitors?
Direct peers on record are EcoSynthetix and CelluForce. Anomera is listed as an emerging player. Broad incumbents are Borregaard, Sappi Biotech, Roquette, Ingredion, CP Kelco and Tate & Lyle. Asahi Kasei is listed as an others.
Does Mirexus Biotechnologies have an API?
No public API is recorded for Mirexus Biotechnologies.
What industry is Mirexus Biotechnologies in?
Mirexus Biotechnologies's product category is Biopolymer Ingredients. Its primary akta.pro industry code is EUAAAIAD, Bio-based Materials & Fibers (e.g., cellulose derivatives, lignin-based materials, nanocellulose), with a secondary code of IMAEAOAE, Cellulose-Based Biodegradable Materials (cellulose films, fibers, derivatives). Its NAICS code is 3252 and its SIC code is 2890.